Kim, S. C., Choi, N., Lee, J., Kwon, K., Eddings, W., Sung, Y., . . . Solomon, D. H. (2016). Uptake of the First Biosimilar Infliximab since its Approval in South Korea. Arthritis Rheumatol.
Stile di citazione ChicagoKim, Seoyoung C., Nam-Kyong Choi, Joongyub Lee, Kyoung-Eun Kwon, Wesley Eddings, Yoon-Kyoung Sung, Hong Ji Song, Aaron S. Kesselheim, e Daniel H. Solomon. "Uptake of the First Biosimilar Infliximab Since Its Approval in South Korea." Arthritis Rheumatol 2016.
Citazione MLAKim, Seoyoung C., et al. "Uptake of the First Biosimilar Infliximab Since Its Approval in South Korea." Arthritis Rheumatol 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.